Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.
- DOI
- 10.3389/fimmu.2022.852563
- Published
- 2022-03-31
- Container
- Front Immunol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2022.852563,
title = {Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.},
author = {Ziemssen T and Arnold DL and Alvarez E and Cross AH and Willi R and Li B and Kukkaro P and Kropshofer H and Ramanathan K and Merschhemke M and Kieseier B and Su W and Häring DA and Hauser SL and Kappos L and Kuhle J.},
year = {2022},
journal = {Front Immunol},
doi = {10.3389/fimmu.2022.852563},
url = {https://doi.org/10.3389/fimmu.2022.852563}
}RIS
TY - JOUR TI - Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials. AU - Ziemssen T AU - Arnold DL AU - Alvarez E AU - Cross AH AU - Willi R AU - Li B AU - Kukkaro P AU - Kropshofer H AU - Ramanathan K AU - Merschhemke M AU - Kieseier B AU - Su W AU - Häring DA AU - Hauser SL AU - Kappos L AU - Kuhle J. PY - 2022 JO - Front Immunol DO - 10.3389/fimmu.2022.852563 UR - https://doi.org/10.3389/fimmu.2022.852563 ER -
APA
T, Z., DL, A., E, A., AH, C., R, W., B, L., P, K., H, K., K, R., M, M., B, K., W, S., DA, H., SL, H., L, K., & J., K. (2022). Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.. Front Immunol. https://doi.org/10.3389/fimmu.2022.852563
Source records
- europe-pmc · retrieved 2026-09-26T17:08:08.168Z
- doaj · retrieved 2026-09-26T17:08:08.176Z